Researchers from Southern Medical University and collaborators report the identification of FDA‑approved compounds that may lower blood lipids by combining computational screening with clinical and ...
In this new article publication from Acta Pharmaceutica Sinica B, authors Wei Wang, Shuo Feng, Zhuyifan Ye, Hanlu Gao, Jinzhong Lin and Defang Ouyang from University of Macau, Macau, China and Fudan ...
Obesity is a complex multifactorial disease associated with an increased risk of several non-communicable diseases. The worldwide prevalence of obesity is approximately 13% of the adult population, ...
In a breakthrough for cardiovascular medicine, researchers have harnessed artificial intelligence to discover unexpected lipid-lowering effects in existing FDA-approved drugs. The study, published in ...
Aberrant sterol lipid metabolism is associated with physiological dysfunctions in the aging brain and aging-dependent disorders such as neurodegenerative diseases. There is an unmet demand to ...
An illustration showing a lipid nanoparticle containing messenger RNA enter a cell. A lipid nanoparticle (LNP) containing messenger RNA (mRNA) enters a cell through an endosome (right). When the LNP ...
In a recent study published in the journal Nature Metabolism, a team of researchers conducted detailed longitudinal profiling and analysis of the lipidome using plasma samples from over a hundred ...
Primary care prescribing data shows that the prescribing of low- and medium-intensity statins across BOB significantly reduced during the scheme period, which continues to be sustained. See ...